Clinical Study

The Presence of Mutations in the K-RAS Gene Does Not Affect Survival after Resection of Pulmonary Metastases from Colorectal Cancer

Table 2

Univariate association of overall and disease-free survival with other variables studied.

VariablesSurvival (95% CI)P DFS (95% CI)P

Previous liver metastasis
 No89.2 (74.1–104.2)0.06470.2 (55.9–84.5)0.017
 Yes58.8 (34.4–83.1)35.9 (17.5–54.3)
DFI
 <12 m63.6 (31.6–75.6)0.07839.4 (17.6–61.2)0.185
 >12 m89.1 (74.3–103.9)68.5 (54.5–82.5)
 <24 m62.5 (47.8–77.1)0.45045.5 (31.1–59.8)0.509
 >24 m89.4 (73.3–105.5)69.3 (59.8–84.6)
 <36 m73.1 (57.3–80.9)0.34753.0 (37.8–68.2)0.119
 >36 m95.3 (74.8–115.7)77.5 (57.9–97.2)
 <48 m79.8 (63.6–95.9)0.12858.8 (43.6–74.1)0.066
 >48 m99.1 (75.8–122.4)81.8 (59.2–104.5)
Sex
 Man82.5 (67.5–97.6)0.51266.2 (50.9–81.5)0.634
 Woman90.5 (63.9–117.1)62.7 (39.5–85.9)
Access
 VATS84.4 (37.8–130.9)0.88083.1 (37.1–128.9)0.685
 Others84.2 (70.2–98.2)63.4 (50.4–76.4)
Complications
 No87.5 (73.2–101.7)0.40668.6 (55.1–82.1)0.023
 Yes46.9 (32.1–61.8)27.1 (7.9–46.3)
Postoperative chemotherapy
 No51.9 (36.6–67.2)0.23333.1 (19.2–46.9)0.213
 Yes97.6 (81.3–113.9)73.7 (58.2–89.3)
Lymph node involvement
 −85.8 (72.1–99.6)0.00867.5 (54.1–80.9)0.001
 +61.4 (19.8–102.9)38.6 (1.2–75.4)
Size
 <1 cm103.3 (83.4–123.3)0.05776.2 (48.8–103.7)0.198
 >1 cm80.0 (66.2–93.8)62.2 (48.9–75.4)
Number
 195.1 (79.8–110.4)0.00174.9 (59.9–89.8)0.000
 >145.9 (29.5–62.4)27.3 (16.1–38.5)
Age
 <65 years104.3 (83.1–125.5)0.05372.4 (51.9–92.8)0.527
 >65 years70.9 (54.9–86.9)59.6 (43.7–75.4)
Comorbidity
 No83.7 (61.6–105.8)0.03353.4 (35.1–71.6)0.040
 Yes87.058 (71.8–102.4)73.7 (56.7–90.7)
Laterality of the metastases
 Right71.4 (59.2–89.6)0.11354.2 (39.8–68.7)0.050
 Left99.5 (75.2–123.3)84.0 (61.4–106.7)
Primary
 Rectum78.3 (62.0–94.6)0.17460.3 (44.5–76.0)0.319
 Colon91.9 (70.7–113.2)71.8 (51.1–92.4)
Preoperative level of CEA
 −99.8 (82.4–117.4)0.02475.4 (58.2–92.7)0.020
 +62.8 (41.1–84.6)45.9 (25.1–66.9)

In all cases, time is measured in months. DFI: disease-free interval; VATS: video-assisted thoracic surgery; CEA: carcinoembryonic antigen.